Test report part 9

File Info : application/pdf, 12 Pages, 4.38MB

Array
(
    [0] => Array
        (
            [url_sha] => 7df148ed7ed28aa6a0d21ca8de738a376b50a2c8ce4746aceb46385e4b4394ba
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=7637700
            [href_text] => Test report part 9
            [href_description] => Resvent Medical Technology Co., Ltd. 0005 RXiBreeze PAP System 2A6LY-0005 2A6LY0005 0005
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=7637700
            [http_size] => 4587805
            [file_sha256] => b4e4d280163d2da09dad1c283ef5d6cc63cc020e39900ea12a25e230a51b1c79
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 7637700
            [file_sha256] => 
            [applicationId] => 8LA6zkGwAMc+OtDymRYn5A==
            [description] => Test report part 9
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Test Report
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 4587807
            [submissionDate] => 2024-09-05 00:00:00
            [dateAvailable] => 2024-09-05 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => 2A6LY-0005
            [cleanFccId] => 2A6LY0005
            [exif] => 0
        )

)